Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
The findings in this whitepaper demonstrate that early detection and intervention are critical in addressing the rising rates of undiagnosed heart valve disease.
A trial on the prevention of heart failure for people who have risk factors for developing heart failure.
Can coronary artery disease be detected early by including a polygenic risk assessment?
A cardiovascular event risk score has been shown to be useful in predicting re-admission and death in patients with coronary heart disease after hospital discharge, and to test whether higher-risk patients benefit from more intensive management.
Benefits for type 2 diabetes of interrupting prolonged sitting.
Biomarkers that highlight toxic fats in the liver.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
Imaging athletes’ hearts during exercise, not at rest.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.Find out more